Loading clinical trials...
Loading clinical trials...
M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study was to assess the Safety and Efficacy of M2951 in participants with S...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
EMD Serono Research & Development Institute, Inc.
Collaborators
NCT07371468 · Systemic Lupus Erythematosus
NCT07617740 · REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
NCT06308978 · Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), and more
NCT07409181 · Systemic Lupus Erythematosus
NCT07043153 · Systemic Lupus Erythematosus Disease
Pinnacle Research Group LLC
Anniston, Alabama
Arizona Arthritis & Rheumatology Associates, P.C.
Mesa, Arizona
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions